Eli Lilly’s UK life sciences investment ‘a pivotal moment’, says analyst – Pharmaceutical Technology
The Eli Lilly Gateway Labs in South San Francisco, California. Credit: Tada Images / Shutterstock. Eli Lilly’s recently-announced investment into the UK’s life sciences sector